Mark T. Lin

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C Mutation

Adrian G. Sacher, Patricia LoRusso, Manish R. Patel et al. · New England Journal of Medicine · 2023 · 294 citations · Full text

Medicine, Oncology, Pharmacology +16

IFN-γ Is Required for Viral Clearance from Central Nervous System Oligodendroglia

Beatriz Parra, David R. Hinton, Norman W. Marten et al. · The Journal of Immunology · 1999 · 217 citations · Full text

Life Sciences, Infectious Diseases, Neuroscience +10

CTL Effector Function Within the Central Nervous System Requires CD4+ T Cells

Stephen A. Stohlman, Cornelia C. Bergmann, Mark T. Lin et al. · The Journal of Immunology · 1998 · 159 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

Laura Kist de Ruijter, Pim P. van de Donk, Jahlisa S. Hooiveld-Noeken et al. · Nature Medicine · 2022 · 127 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Jayesh Desai, Guzmán Alonso, Se Hyun Kim et al. · Nature Medicine · 2023 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17